ATRIAL FIBRILLATION AND STROKE PREVENTION PRACTICES IN PATIENTS WITH CANDIDACY FOR ANTICOAGULATION THERAPY

Insights

Many atrial fibrillation patients at high risk for stroke are not receiving adequate anticoagulant therapy. This study highlights a gap in stroke prevention practices for these individuals.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Atrial Fibrillation (AF) increases stroke risk due to left atrial thrombi.
  • Antithrombotic therapy, primarily Vitamin K antagonists (VKAs), is recommended for AF patients.
  • This study assessed stroke prevention in local AF patients eligible for anticoagulation.

Purpose of the Study:

  • To evaluate current stroke prevention strategies in patients with Atrial Fibrillation.
  • To identify the prevalence of appropriate anticoagulation use in high-risk AF patients.
  • To determine adherence to stroke prevention guidelines in a local population.

Main Methods:

  • A descriptive cross-sectional study was conducted in Peshawar, Pakistan.
  • Included patients with EKG-confirmed AF and a CHA2DS2-VASc score ≥ 2 or mitral stenosis.
  • Excluded patients with other indications for anticoagulation.

Main Results:

  • 205 AF patients were studied; 72.7% were candidates for anticoagulation.
  • Only 27.5% received adequate anticoagulant therapy (VKAs or novel oral anticoagulants).
  • Most patients received dual antiplatelet therapy (DAPT) instead of anticoagulation.

Conclusions:

  • A significant proportion of high-risk AF patients are undertreated for stroke prevention.
  • Current stroke prevention practices for AF patients in this region are suboptimal.
  • There is a critical need to improve the initiation and management of antithrombotic therapy in AF.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
463
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
613
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
372
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
563